Jointly developed the next-generation antibody VHH humanized library "PharmaLogicalTM Library" with Mitsui Information Co., Ltd. from Japan.

Mitsui Information Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Kengo Asano, hereinafter referred to as Mitsui Information) and Epsilon Molecular Engineering Co., Ltd. (Headquarters: Saitama City, Saitama Prefecture, President: Naoto Nemoto, hereinafter referred to as EME) announced the completion of the joint development of the PharmaLogical Library, Japan's first next-generation humanized library of VHH antibodies for drug discovery, and its transition to the implementation phase. Mitsui Information and EME will continue to utilize the PharmaLogical Library to acquire, design, and optimize VHH antibodies that lead to drug discovery, thereby supporting pharmaceutical companies in improving the speed of research and the reliability of drug development.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related Documents
Related Links
Mitsui Information Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Kengo Asano, hereinafter referred to as Mitsui Information) and Epsilon Molecular Engineering Co., Ltd. (Headquarters: Saitama City, Saitama Prefecture, President: Naoto Nemoto, hereinafter referred to as EME) announced the completion of the co-development of the PharmaLogical™ Library, Japan's first (*1) next-generation antibody VHH (*2) humanized library for drug discovery, and its transition to the implementation phase.